Q32 bio

Q32 Bio is a privately held biotechnology company centered on restoring immune system balance. Their therapeutics target regulators of the innate and adaptive immune systems in patients with severe inflammatory and autoimmune diseases. 

Referred to us by Argot Partners, Q32 Bio needed scientific illustrations and investor presentation redesign to enhance their deck for the Jefferies Healthcare Conference. The project required several scientific and conceptual graphics, including mechanism of action (MOA) illustrations for Q32 Bio’s two lead programs. 

Our process began with educating ourselves on the scientific concepts through a review of materials and interviews with the subject matter team. Drawing on our unique knowledge of science and marketing, we developed an investor presentation that translated complex science into a simple message and engaging visual graphics. 

We were delighted to be working again with Q32 Bio CEO Michael Broxson, formerly of Goldfinch Bio. Mike had this to say of the results:

“We had a good Jefferies conference last week; deck looked great and feedback was positive. Thanks for your heroic efforts to make that possible.” Mike Broxson, CEO

This slide from Q32 Bio illustrates their therapeutic approach to harness both the innate and adaptive immune responses. It shows a Venn diagram overlapping a human silhouette, with the left circle representing adaptive immunity and their ADX-914 targeting the IL-7/TSLP receptor, and the right circle representing innate immunity and their ADX-097 targeting Convertase. The central message highlights delivering novel therapeutics to achieve immune homeostasis in serious innate and adaptive immune system disorders.
This slide outlines Q32 Bio's vision and mission in achieving immune homeostasis. Their vision is 'Empowering patients with debilitating immune disorders to regain control of their lives,' and their mission is 'Delivering breakthrough medicines to quiet the storm of an overactive immune system.' The central focus, connected by a cyclical arrow, is 'Delivering novel therapeutics to achieve immune homeostasis in serious innate and adaptive immune system disorders.